ERK5 Activation Inhibits Inflammatory Responses via Peroxisome Proliferator-activated Receptor δ (PPARδ) Stimulation*

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Biological Chemistry

• Publication date

  2006-10-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1074/jbc.M602369200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Inducible Nitric-oxide Synthase and NO Donor Induce Insulin Receptor Substrate-1 Degradation in Skeletal Muscle Cells*

  2005cited by this paper
• Regulatory role of peroxisome proliferator-activated receptor delta (PPAR delta) in muscle metabolism. A new target for metabolic syndrome treatment?

  2005cited by this paper
• Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure.

  2005cited by this paper
• The Hinge-Helix 1 Region of Peroxisome Proliferator-Activated Receptor γ1 (PPARγ1) Mediates Interaction with Extracellular Signal-Regulated Kinase 5 and PPARγ1 Transcriptional Activation: Involvement in Flow-Induced PPARγ Activation in Endothelial Cells

  2004cited by this paper
• Bilirubin From Heme Oxygenase-1 Attenuates Vascular Endothelial Activation and Dysfunction

  2004cited by this paper
• Regulation of Muscle Fiber Type and Running Endurance by PPARδ

  2004cited by this paper
• Adenoviral transfer of the heme oxygenase-1 gene protects striatal astrocytes from heme-mediated oxidative injury.

  2004cited by this paper
• Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients.

  2004cited by this paper
• Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism.

  2003cited by this paper
• Suppression of Inflammatory Cytokine Production by Carbon Monoxide Involves the JNK Pathway and AP-1*

  2003cited by this paper
• Regulation of Epidermal Growth Factor-induced Connexin 43 Gap Junction Communication by Big Mitogen-activated Protein Kinase 1/ERK5 but Not ERK1/2 Kinase Activation*

  2003cited by this paper
• Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ

  2003cited by this paper
• Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

  2003cited by this paper
• Inhibition of Tumor Necrosis Factor-&agr;–Induced SHP-2 Phosphatase Activity by Shear Stress: A Mechanism to Reduce Endothelial Inflammation

  2003cited by this paper
• Systemic Rather Than Local Heme Oxygenase-1 Overexpression Improves Cardiac Allograft Outcomes in a New Transgenic Mouse1

  2003cited by this paper
• Physiological and Therapeutic Roles of Peroxisome Proliferator-Activated Receptors

  2002cited by this paper
• PPARα and PPARδ activators inhibit cytokine-induced nuclear translocation of NF-κB and expression of VCAM-1 in EAhy926 endothelial cells

  2002cited by this paper
• Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat.

  2002cited by this paper
• Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway

  2002cited by this paper
• Expression of fatty acid binding proteins inhibits lipid accumulation and alters toxicity in L cell fibroblasts.

  2002cited by this paper
• Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle

  2001cited by this paper
• Molecular Cloning of Mouse ERK5/BMK1 Splice Variants and Characterization of ERK5 Functional Domains*

  2001cited by this paper
• Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway

  2000cited by this paper
• ERK5 Is a Novel Type of Mitogen-Activated Protein Kinase Containing a Transcriptional Activation Domain

  2000cited by this paper
• Role of redox-regulated transcription factors in inflammation, aging and age-related diseases.

  2000cited by this paper
• Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans.

  2000cited by this paper
• Adaptive responses and apoptosis in endothelial cells exposed to carbon monoxide.

  2000cited by this paper
• Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions.

  1999cited by this paper
• Evidence for iNOS-dependent peroxynitrite production in diabetic platelets

  1999cited by this paper
• Fatty acid-induced β cell apoptosis: A link between obesity and diabetes

  1998cited by this paper
• Terminal differentiation of human breast cancer through PPAR gamma.

  1998cited by this paper
• Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor

  1998cited by this paper
• Biology of cachexia.

  1997cited by this paper
• Heme Oxygenase-mediated Resistance to Oxygen Toxicity in Hamster Fibroblasts*

  1997cited by this paper
• Regulation of Peroxisome Proliferator-activated Receptor γ Activity by Mitogen-activated Protein Kinase*

  1997cited by this paper
• Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase.

  1997cited by this paper
• BMK1/ERK5 regulates serum‐induced early gene expression through transcription factor MEF2C

  1997cited by this paper
• Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation via protein kinase C.

  1995cited by this paper
• Primary structure of BMK1: a new mammalian map kinase.

  1995cited by this paper
• Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators.

  1994cited by this paper

• Diet-induced chromatin states influence intestinal stem cell memory

  2026cites this paper
• Guan-Xin-Kang and Its Active Compound Astragaloside IV Improve Atherosclerosis Through Extracellular Signal-Regulated Kinase 5-Mediated Macrophage Efferocytosis

  2025cites this paper
• Silymarin prevents endothelial dysfunction by upregulating Erk-5 in oxidized LDL exposed endothelial cells.

  2024cites this paper
• The significance of ERK5 catalytic-independent functions in disease pathways

  2023influential citation
• Flow-induced reprogramming of endothelial cells in atherosclerosis

  2023cites this paper
• Statin-regulated phagocytosis and efferocytosis in physiological and pathological conditions.

  2022cites this paper
• Neutrophil dynamics and inflammaging in acute ischemic stroke: A transcriptomic review

  2022cites this paper
• Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH

  2021cites this paper
• Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy

  2020cites this paper
• Distinct peripheral blood monocyte and neutrophil transcriptional programs following intracerebral hemorrhage and different etiologies of ischemic stroke

  2020cites this paper
• SUMO proteins in the cardiovascular system: friend or foe?

  2020cites this paper
• Biochanin A protects against PM2.5-induced acute pulmonary cell injury by interacting with the target protein MEK5.

  2019cites this paper
• Effect of redox imbalance on protein modifications in lymphocytes of psoriatic patients.

  2019cites this paper
• Gypenoside A protects ischemia/reperfusion injuries by suppressing miR-143-3p level via the activation of AMPK/Foxo1 pathway.

  2019cites this paper
• Inhibition of microRNA‐143‐3p attenuates myocardial hypertrophy by inhibiting inflammatory response

  2018influential citation
• Ponatinib Activates an Inflammatory Response in Endothelial Cells via ERK5 SUMOylation

  2018cites this paper
• Ionizing Radiation Induces Endothelial Inflammation and Apoptosis via p90RSK-Mediated ERK5 S496 Phosphorylation

  2018cites this paper
• Insights into the Role of PPARβ/δ in NAFLD

  2018cites this paper
• Flow signaling and atherosclerosis

  2017cites this paper
• Dipeptidyl Peptidase‐4 Inhibitor Anagliptin Prevents Intracranial Aneurysm Growth by Suppressing Macrophage Infiltration and Activation

  2017cites this paper
• ERK5 regulates tobacco smoke‑induced urocystic epithelial‑mesenchymal transition in BALB/c mice.

  2017cites this paper
• Increased T-cell Infiltration Elicited by Erk5 Deletion in a Pten-Deficient Mouse Model of Prostate Carcinogenesis.

  2017cites this paper
• Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.

  2016cites this paper
• The Ubiquitin-Like SUMO System and Heart Function: From Development to Disease.

  2016cites this paper
• EGCG Suppresses ERK5 Activation to Reverse Tobacco Smoke-Triggered Gastric Epithelial-Mesenchymal Transition in BALB/c Mice

  2016cites this paper
• Kinase-SUMO networks in diabetes-mediated cardiovascular disease.

  2016cites this paper
• Disturbed Flow-Induced Endothelial Proatherogenic Signaling Via Regulating Post-Translational Modifications and Epigenetic Events

  2016cites this paper
• Effect of PPARδ agonist on stearoyl-CoA desaturase 1 in human pancreatic cancer cells: role of MEK/ERK1/2 pathway.

  2015cites this paper
• ERK5 positively regulates cigarette smoke-induced urocystic epithelial-mesenchymal transition in SV‑40 immortalized human urothelial cells.

  2015cites this paper
• Extracellular signal–regulated kinase 5 promotes acute cellular and systemic inflammation

  2015cites this paper
• A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4–ERK5 axis

  2015cites this paper
• Platelet Extracellular Regulated Protein Kinase 5 Is a Redox Switch and Triggers Maladaptive Platelet Responses and Myocardial Infarct Expansion

  2015cites this paper
• PPARs: Protectors or Opponents of Myocardial Function?

  2015cites this paper
• Role for SUMOylation in disturbed flow-induced atherosclerotic plaque formation

  2015cites this paper
• Vascular endothelial cell Toll-like receptor pathways in sepsis

  2015cites this paper
• The oncoprotein HBXIP enhances migration of breast cancer cells through increasing filopodia formation involving MEKK2/ERK1/2/Capn4 signaling.

  2014cites this paper
• Novel Mechanisms of Endothelial Mechanotransduction

  2014cites this paper
• ERK5 Activation in Macrophages Promotes Efferocytosis and Inhibits Atherosclerosis

  2014cites this paper
• Shear Stress and Atherosclerosis

  2014cites this paper
• Therapeutic Potential of HO-1 in Autoimmune Diseases

  2014cites this paper
• Identification of Activators of ERK5 Transcriptional Activity by High-Throughput Screening and the Role of Endothelial ERK5 in Vasoprotective Effects Induced by Statins and Antimalarial Agents

  2014cites this paper
• Nuclear Control of the Inflammatory Response in Mammals by Peroxisome Proliferator-Activated Receptors

  2013cites this paper
• Carbon monoxide: mechanisms of action and potential clinical implications.

  2013cites this paper
• Cardiac nuclear high mobility group box 1 prevents the development of cardiac hypertrophy and heart failure

  2013cites this paper
• Statins protect human endothelial cells from TNF-induced inflammation via ERK5 activation.

  2013cites this paper
• De-SUMOylation Enzyme of Sentrin/SUMO-Specific Protease 2 Regulates Disturbed Flow–Induced SUMOylation of ERK5 and p53 that Leads to Endothelial Dysfunction and Atherosclerosis

  2013cites this paper
• Role of Inflammation and Its Mediators in Acute Ischemic Stroke

  2013cites this paper
• Laminar Flow Activation of ERK5 Protein in Vascular Endothelium Leads to Atheroprotective Effect via NF-E2-related Factor 2 (Nrf2) Activation*

  2012cites this paper
• p90RSK Targets the ERK5-CHIP Ubiquitin E3 Ligase Activity in Diabetic Hearts and Promotes Cardiac Apoptosis and Dysfunction

  2012cites this paper
• The role of carbon monoxide as a gasotransmitter in cardiovascular and metabolic regulation

  2012cites this paper
• Carbon monoxide transport and actions in blood and tissues.

  2011cites this paper
• Cardiac function and disease: emerging role of small ubiquitin‐related modifier

  2011cites this paper
• Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis

  2011cites this paper
• PKCζ mediates disturbed flow-induced endothelial apoptosis via p53 SUMOylation

  2011cites this paper
• Apoptotic cell-derived factors induce arginase II expression in murine macrophages by activating ERK5/CREB

  2011cites this paper
• Regulation of Squamous Cell Carcinoma Carcinogenesis by Peroxisome Proliferator-Activated Receptors

  2011cites this paper
• Disturbed-flow-mediated vascular reactive oxygen species induce endothelial dysfunction.

  2011cites this paper
• Laminar flow activation of ERK5 leads to cytoprotective effect via CHIP-mediated p53 ubiquitination in endothelial cells

  2011cites this paper
• Calcium Regulation of EGF-Induced ERK5 Activation: Role of Lad1-MEKK2 Interaction

  2010cites this paper
• PPAR d and PGC 1 a act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress

  2010cites this paper
• PPARdelta and PGC1alpha act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress.

  2010cites this paper
• Medicinal Chemistry and Therapeutic Applications of the Gasotransmitters NO, CO, and H2S and their Prodrugs

  2010cites this paper
• PKCzeta decreases eNOS protein stability via inhibitory phosphorylation of ERK5.

  2010cites this paper
• Identification of novel trophoblast invasion-related genes: heme oxygenase-1 controls motility via peroxisome proliferator-activated receptor gamma.

  2009cites this paper
• Sorting out the functional role(s) of peroxisome proliferator- activated receptor-β/δ (PPARβ/δ) in cell proliferation and cancer

  2009cites this paper
• Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer.

  2009cites this paper
• PPARgamma inhibits NF-kappaB-dependent transcriptional activation in skeletal muscle.

  2009cites this paper
• Mitogen activated protein kinases: a role in inflammatory bowel disease?

  2009cites this paper
• Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines

  2008cites this paper
• Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease.

  2008cites this paper
• Peroxisome proliferator activated receptor gamma agonists suppress TNFalpha-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species.

  2008cites this paper
• Peroxisome proliferator-activated receptors: a therapeutic target in COPD?

  2008cites this paper
• PPARs Mediate Lipid Signaling in Inflammation and Cancer

  2008cites this paper
• Ligand activation of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms

  2008cites this paper
• Naringenin has anti-inflammatory properties in macrophage and ex vivo human whole-blood models.

  2008cites this paper
• Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.

  2008cites this paper
• Heme oxygenase and carbon monoxide initiate homeostatic signaling

  2008cites this paper
• ReviewArticle PPARs Mediate Lipid Signaling in Inflammation and Cancer

  2008cites this paper
• Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands do not potentiate growth of human cancer cell lines

  2007cites this paper
• Ligand activation of peroxisome proliferator-activated receptor-β/δ(PPARβ/δ) inhibits cell growth of human N/TERT-1 keratinocytes

  2007cites this paper
• Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms.

  2007cites this paper